Can we measure effectiveness of new cystic fibrosis treatments in improving lung health in children with cystic fibrosis aged less than 2 years of age during clinical trials conducted for the approval of new medicines?
Testing blood for antibodies against the bacteria Pseudomonas aeruginosa to track early antibiotic treatment
Inflammation and infection change what mucus is made of, how much gets made, and how much it can dissolve
How does infection with Pseudomonas and Aspergillus affect people with cystic fibrosis? A study using UK registry data.
Inhaled antibiotic use is associated with Scedosporium/Lomentospora species isolation in cystic fibrosis
Glycosaminoglycans are differentially involved in bacterial binding to healthy and cystic fibrosis lung cells.
Characteristics and outcomes of oral antibiotic treated pulmonary exacerbations in children with cystic fibrosis.
